Versant Capital Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,380
Closed -$32.9K – 2806
2026
Q2
$32.9K Buy
1,380
+1,135
+463% +$21.8K ﹤0.01% 1654
2026
Q1
$4.32K Hold
245
– – ﹤0.01% 2422
2025
Q4
$4.84K Hold
245
– – ﹤0.01% 2264
2025
Q3
$4.28K Sell
245
-7
-3% -$104 ﹤0.01% 2266
2025
Q2
$3.53K Buy
252
+79
+46% +$1.27K ﹤0.01% 2270
2025
Q1
$3.22K Buy
+173
New +$2.58K ﹤0.01% 2183
2023
Q3
– Sell
-102
Closed -$587 – 1939
2023
Q2
$587 Buy
+102
New +$660 ﹤0.01% 1785

Other funds holding ALHC

Versant Capital Management's ALHC Position: Q3 2026 in Review

Versant Capital Management sold out of Alignment Healthcare (ALHC) in Q3 2026, closing a stake of 1,380 shares — an estimated $32.9K sold.

Versant Capital Management first reported a position in ALHC in Q2 2023 and held it in 7 quarters. The position peaked at $32.9K in Q2 2026. 118 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • Versant Capital Management reported no remaining Alignment Healthcare position as of Q3 2026 after selling out during the quarter.
  • Versant Capital Management sold 1,380 Alignment Healthcare shares in Q3 2026, an estimated $32.9K.
  • Versant Capital Management first reported a position in Alignment Healthcare in Q2 2023 and held it in 7 quarters.
  • Versant Capital Management's Alignment Healthcare position peaked at $32.9K in Q2 2026.
  • 118 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.